deoxyepinephrine has been researched along with Diabetes Mellitus, Type 1 in 1 studies
Deoxyepinephrine: Sympathomimetic, vasoconstrictor agent.
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Diabetes mellitus was assessed by investigating 8 type I diabetic patients, in good metabolic control and with congestive heart failure, who were studied after 3 weeks of placebo and ibopamine (100 mg t." | 9.06 | Ibopamine does not affect insulin resistance in patients with type I diabetes. ( Benzi, L; Cecchetti, P; Ciccarone, AM; Cicchetti, V; Di Cianni, G; Navalesi, R; Sabino, F, 1990) |
| "Diabetes mellitus was assessed by investigating 8 type I diabetic patients, in good metabolic control and with congestive heart failure, who were studied after 3 weeks of placebo and ibopamine (100 mg t." | 5.06 | Ibopamine does not affect insulin resistance in patients with type I diabetes. ( Benzi, L; Cecchetti, P; Ciccarone, AM; Cicchetti, V; Di Cianni, G; Navalesi, R; Sabino, F, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benzi, L | 1 |
| Sabino, F | 1 |
| Ciccarone, AM | 1 |
| Cecchetti, P | 1 |
| Di Cianni, G | 1 |
| Cicchetti, V | 1 |
| Navalesi, R | 1 |
1 trial available for deoxyepinephrine and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Ibopamine does not affect insulin resistance in patients with type I diabetes.
Topics: Adult; Blood Glucose; Cardiotonic Agents; Deoxyepinephrine; Diabetes Mellitus, Type 1; Female; Heart | 1990 |